EQT agrees to acquire Zeus from the Tourville family
Summary
Zeus’ components enable the delivery of minimally invasive interventional procedures, aiming to drive better health outcomes than traditional open surgeries, including faster patient recovery and reduced pain, at lower cost. These investments will enable the company to continue partnering with its clients’ research and development groups to remain at the forefront of next generation technologies. We are committed to strengthening the partnerships with the customers that Zeus serves and expanding capacity through investments, operational upgrades, and growth from new product innovations. This acquisition represents a highly thematic investment for EQT, given our long-time focus on the medical technology industry and our experience partnering with family-founded businesses. With EQT’s deep expertise and broad network of advisors in the healthcare sector, we look forward to continuing our track record of creating differentiated value for all stakeholders."